COMMD9

Across TCGA pan-cancer cohorts, COMMD9 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated COMMD9 data layer compared with 23 for mass-spec protein and 6 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher COMMD9 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated COMMD9 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

COAD and UCEC are the cancer types where COMMD9 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.113	0.806	<.001	9	view →
UCEC	DFS	Median	II,III,IV	0.915	0.441	.045	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

COMMD9–COAD (OS)

Open the COAD breakdown →